लोड हो रहा है...

New and future immunomodulatory therapy in type 1 diabetes

Type 1 diabetes is a common autoimmune disease that affects millions of people worldwide and has an incidence that is increasing at a striking rate, especially in young children. It results from the targeted self-destruction of the insulin-secreting β cells of the pancreas and requires lifelong insu...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Tooley, James E., Waldron-Lynch, Frank, Herold, Kevan C.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2012
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586241/
https://ncbi.nlm.nih.gov/pubmed/22342807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2012.01.001
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!